CTOs on the Move

Femasys

www.femasys.com

 
Our experienced management team has over 200 years of collective industry experience with extensive focus in medical devices. The pioneering and collaborative efforts of the management team have created an organization that strives for integrity in all actions, innovation in development activities, excellence in operations, and the highest quality products. The team is complemented by world-class medical advisors. Our products have been organically conceived, researched and developed by the Company and all manufacturing activities are conducted to ensure compliance with the U.S. Food and Drug Administration (FDA) per the requirements of 21 CFR 820, as well as ISO 13485. Femasys ...
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million
  • www.femasys.com
  • 5000 Research Court Suite 100
    Suwanee, GA USA 30024
  • Phone: 770.500.3910

Executives

Name Title Contact Details

Funding

Femasys raised $10M on 05/01/2015

Similar Companies

American Hearing Aid Associates

American Hearing Aid Associates is a Chadds Ford, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Biolinq

Biolinq develops skin-applied electrochemical sensors that analyze body fluids to provide actionable health information. Get blood level info, without accessing blood.

Value-Tek

Value-Tek is a Phoenix, AZ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Accusync Medical Research Corp

Accusync Medical Research Corp is a Milford, CT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

CeQur

CeQur is dedicated to helping people with type 2 diabetes manage their disease by developing and commercializing simple drug delivery devices that can be easily integrated into daily life. The company`s lead product, PaQ, is a wearable insulin delivery device that delivers both basal and bolus insulin for 3 days at a time. Its simple, discreet design enables people to easily experience the benefits of intensive insulin therapy, while remaining free from the burdens of daily insulin injections. CeQur SA was established in January 2008 as a spinout from Danfoss A/S, a global Danish industrial products group that developed the initial concept of the CeQur technology. CeQur recently completed a clinical study evaluating PaQ among people with type 2 diabetes with positive results. The company has advanced the technology to a commercial product obtaining a CE mark for PaQ in 2012. CeQur is headquartered in Horw, Switzerland, with operations in Nordborg, Denmark and Marlborough, Massachusetts.